NR3C1 and major depressive disorder: Based on the above-mentioned observations in humans and in animal models, suggesting a deregulation of GR functioning, several strategies targeting directly GR were tested in AD and MDD, and seem to have an important therapeutic potential (Bachmann et al., 2003; Caraci et al., 2010; Figure 2).